1 false false false false false false false false false false true false false false false false false No description of principal activity 2025-04-15 Sage Accounts Production Advanced 2025 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 16390345 2025-04-15 2026-04-30 16390345 2026-04-30 16390345 2025-04-14 16390345 bus:Director1 2025-04-15 2026-04-30 16390345 core:WithinOneYear 2026-04-30 16390345 bus:Micro-entities 2025-04-15 2026-04-30 16390345 bus:AuditExemptWithAccountantsReport 2025-04-15 2026-04-30 16390345 bus:SmallCompaniesRegimeForAccounts 2025-04-15 2026-04-30 16390345 bus:PrivateLimitedCompanyLtd 2025-04-15 2026-04-30 16390345 bus:FullAccounts 2025-04-15 2026-04-30
COMPANY REGISTRATION NUMBER: 16390345
VDostal Medical Ltd
Unaudited financial statements
30 April 2026
VDostal Medical Ltd
Statement of financial position
30 April 2026
30 Apr 26
£
£
Current assets
96,119
Creditors: amounts falling due within one year
( 30,518)
-------
Net current assets
65,601
-------
Total assets less current liabilities
65,601
Accruals and deferred income
( 2,340)
-------
63,261
-------
Capital and reserves
63,261
-------
Notes to the financial statements
1. Employee numbers
The average number of employees during the period was 1 .
2. Director's advances, credits and guarantees
As at 30 April 2026, the director owed the Company £50,596. No interest has been charged on this amount.
For the period ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 23 September 2026 , and are signed on behalf of the board by:
Dr V Dostal
Director
Company registration number: 16390345
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 19 Leicester Street, Norwich, NR2 2AS, United Kingdom.